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Physicians’ perspectives on clinical
pharmacy services in Northern Sweden:
a qualitative study
Charlotta Vinterflod1, Maria Gustafsson1*, Sofia Mattsson1 and Gisselle Gallego1,2
Abstract
Background: In many countries, clinical pharmacists are part of health care teams that work to optimize drug
therapy and ensure patient safety. However, in Sweden, clinical pharmacy services (CPSs) in hospital settings have
not been widely implemented and regional differences exist in the uptake of these services. Physicians’ attitudes
toward CPSs and collaborating with clinical pharmacists may facilitate or hinder the implementation and expansion
of the CPSs and the role of the clinical pharmacist in hospital wards. The aim of this study was to explore physicians’
perceptions regarding CPSs performed at hospital wards in Northern Sweden.
Methods: Face-to-face semi-structured interviews were conducted with a purposive sample of nine physicians who
had previously worked with clinical pharmacists between November 2014 and January 2015. Interviews were digitally
recorded, transcribed and analysed using a constant comparison method.
Results: Different themes emerged regarding physicians’ views of clinical pharmacy; two main interlinked themes were
service factors and pharmacist factors. The service was valued and described in a positive way by all physicians. It was
seen as an opportunity for them to learn more about pharmacological treatment and also an opportunity to discuss
patient medication treatment in detail. Physicians considered that CPSs could improve patient outcomes and they
valued continuity and the ability to build a trusting relationship with the pharmacists over time. However, there was a
lack of awareness of the CPSs. All physicians knew that one of the pharmacist’s roles is to conduct medication reviews,
but most of them were only able to describe a few elements of what this service encompasses. Pharmacists were
described as “drug experts” and their recommendations were perceived as clinically relevant. Physicians wanted CPSs
to continue and to be implemented in other wards.
Conclusions: All physicians were positive regarding CPSs and were satisfied with the collaboration with the clinical
pharmacists. These findings are important for further implementation and expansion of CPSs, particularly in
Northern Sweden.
Keywords: Clinical pharmacy, Physicians, Collaboration, Hospital, Sweden
Background
Problems associated with drug treatment such as adverse
drug reactions (ADRs), medication errors and adverse
drug events (ADEs) are common. ADEs can result in
drug-related morbidity and mortality, and studies show
that from seven up to approximately 30% of hospital
admissions are directly related to drug treatment
problems [1–5]. According to a study conducted in
Northern Sweden in 2016, as much as 41% of hospital
admissions were judged as drug-related among old people
with dementia [6]. Moreover, according to one meta-
analysis, up to 24% of patients develop ADRs during their
hospital stay [7].
There is a clear need for interventions that decrease
drug-related problems (DRPs) and improve patient safety,
for example by implementing clinical pharmacy services
(CPSs) in hospitals. A systematic review conducted by
Graabaek et al., described that clinical pharmacy services
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in the hospital ward resulted in positive effects on medica-
tion use, health service use and costs [8]. Furthermore,
research has shown that collaboration between physicians
and pharmacists has the potential to reduce DRPs, emer-
gency department visits and hospitalization [8–14]. For
example a study by Gillespie et al., demonstrated that
including a clinical pharmacist in a health care team
reduced drug-related readmissions by 80% among people
80 years and older in an internal medicine ward in
Uppsala, Sweden [15].
Although clinical pharmacists have been an integral part
of health care for several years in countries like the United
States [9], CPSs have not been widely implemented across
Swedish hospitals. This applies particularly to Northern
Sweden. Västerbotten County is one of five counties situ-
ated in Norrland, the most northerly region of Sweden.
Norrland is the largest geographical area, covering about
59% of Sweden’s total surface area. The population living
in the region is about 12% of Sweden’s total population of
approximately 10 million [16, 17]. The relatively small
numbers of patients dispersed over large geographic areas,
together with shortage of health care professionals pose
special challenges for the provision of health services in
this region. Each of Sweden’s 21 county councils sets their
own strategies and policies for the inclusion of clinical
pharmacy. Most of the county councils that employ
clinical pharmacists are based in Southern Sweden and
therefore only certain cities and hospitals have access to
CPSs around Sweden.
Physicians’ attitudes toward CPSs and collaborating
with clinical pharmacists may facilitate or hinder the
implementation and expansion of the CPSs and the role
of the clinical pharmacist in hospital wards. To date,
however, there have been no qualitative studies explor-
ing physicians’ perceptions of CPSs in hospital settings
in Sweden. The aim of this study was therefore to ex-
plore physicians’ perceptions regarding CPSs performed
in hospitals operated by Västerbotten County Council.
Method
This study took place in three hospital wards (one
geriatric ward and two internal medical wards) in Norr-
lands University Hospital, situated in Västerbotten
County, Sweden.
Context
CPS started as a project within Västerbotten County
Council in 2002. Today, there are six clinical pharma-
cists active in inpatient and outpatient care in Västerbot-
ten. The service provided by the clinical pharmacists
working in inpatient care consists of medication recon-
ciliation, medication review (sometimes including pa-
tient counselling and participation in ward rounds.
Table 1 describes the CPSs.
The interview guide
An interview guide was developed based on a review of
the literature and discussions within the research team.
The schedule focused on three main topics: the pharma-
cist role on the ward, clinical outcomes of CPSs, and
future role of CPS (See Additional file 1). A pilot test
interview was conducted to determine the suitability of
the questions. After the test, interview questions that the
respondent thought were difficult to answer were changed
or reworded. The pilot interview also served as a learning
process for the interviewer and gave the opportunity to
improve the interviewing schedule.
Participant selection
A purposive sample, that is, a sample that would serve the
purpose of the study was used [18]. Physicians who had
previously worked with clinical pharmacists, on five differ-
ent wards, and who were familiar with the type of services
pharmacists provide (i.e. had to have several encounters
and interactions with the clinical pharmacists) were
invited to participate after approval was granted by the
ward managers. Those who did not respond to the first
email were sent two reminders. Since data saturation [19]
(i.e. no new categories or themes emerged from the data)
was achieved after the ninth interview, no further at-
tempts were made to contact those who did not respond.
Data collection
Face-to-face semi-structured interviews were conducted
in Swedish by the first author (CV) between November
2014 and January 2015. The interviews lasted between
15 and 35 min and were based around the interview
schedule.
Data analysis
Interviews were digitally recorded and transcribed. Partici-
pants were given the opportunity to read and comment
on their transcribed interviews. Only one participant read
Table 1 Clinical pharmacy services provided in Northern
Swedish hospitals
When How often Activity
At admission Once for each patient Admission medication
reconciliation
During
hospital stay
As long as the patient
is still in the hospital
ward
Medication review and
monitoring
In some wards,
depending on need
and time
Patient counselling
When clinical relevant
DRPs are found
Discussion with responsibly
physician (for example
participating in ward rounds)
At discharge Occasionally Discharge medication
reconciliation
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the transcript but provided no comments. The data ana-
lysis was completed in several stages: after each interview,
a preliminary data analysis was performed to allow the
identification of issues that needed to be further investi-
gated in the following interviews. After this first step, a
continuous analysis of collected data was performed and a
coding framework was developed by CV and GG. Seg-
ments (paragraphs, sentences) were coded and labelled
using colours and comments in Microsoft Office Word.
Coded segments were then compared for differences and
similarities of events and ideas. This process was repeated
until all comments were assigned to categories [20].
To verify the identification of themes, the researchers
discussed the mapping and coding framework on several
occasions. One interview was coded by a second coder
(SM). This allowed a clearer definition of categories and
further discussion of the meaning of the codes [21]. The
coded interviews were compared, differences were
discussed by the researchers and a joint decision on
what coding should be used for the segment was taken.
Results
Twenty-two physicians were invited to take part in the
study and nine agreed to participate. Two physicians did
not have time and no response was received from eleven.
As previously mentioned, data saturation was reached
after nine interviews so no attempts were made to contact
these physicians. The characteristics of the participants
are described in Table 2. Most physicians worked in
internal medical wards, and a few physicians in a geriatric
ward. On average physicians had been working with
clinical pharmacists for 4.8 years (range 1–10 years).
The interviews drew out a broad range of views
regarding CPSs in hospital wards (Fig. 1). To illustrate the
findings quotes were selected and translated from Swedish
to English. The translations were back-translated by an
experienced qualitative researcher who is also fluent in
Swedish and English.
The clinical pharmacy service
All physicians used positive terms to describe the clinical
pharmacy service. Some highlighted the fact that they
especially appreciated having had the opportunity to
discuss each patient systematically with the pharmacist.
However, physicians’ views varied; some mentioned that
medication review is an important task they would like
to perform themselves. But as it saves them time, they
are happy to leave that task to the pharmacist. As one of
the physicians noted: “It's a pretty big task to do it
[medication review] for every patient, and you might
wish that you had the time to do it yourself, but you just
can’t cope with that, can you?” (P7).
A general view voiced by physicians in this study is that
medication reviews are time consuming. Some mentioned
that medication reviews are not given a high priority, as
physicians have to maximize their time and therefore
focus mostly on the acute medical problem. As one phys-
ician said, “You can't spend a whole day trying to figure
out and read up on and find articles [about interactions]
to help one patient.” (P6).
However, others stated that medication reviews not
only “save them time” but when also done by a profes-
sional perceived to have “more knowledge of drugs”. This
can be seen in the account from this physician: “It takes
up a good-sized space and saves me a lot of time.
Actually, that somebody who knows, and has experience,
has gone through it in a structured way, gone through the
medication lists.” (P4).
Another physician commented: “Then I think it has been
very nice, because it has been a forum for discussion.
Nobody has been pulling rank, instead it has been an
opportunity to talk a little about the patient.” (P5).
Several of the physicians mentioned that medication re-
view is an opportunity to learn more about drugs and
medication treatment. Some of the participants commen-
ted that it has helped them become “better physicians”.
“I believe that the work this pharmacist has done has
been really good because it has become a revision and
a learning process for us about, yes, interactions. It
could be specific drugs, how they work together with
other drugs or in combination with reduced renal
function and things like that, and there is always a
need to learn more about this.” (P2)
Following recommendations
Regarding the question of what kind of recommenda-
tions the pharmacist provides physicians with, the an-
swers included: drug interactions, dose adjustments,
side-effects, inappropriate drugs to certain patient
groups (e.g. the elderly), drug changes, combinations of
drugs, discontinuation of a drug, administration time,
Table 2 Participant characteristics
Interviewee
number
Age Gender Years
working as
physician
Years
working
with
pharmacist
Number of
meetings with
pharmacist
P1 30–40 Male 4.5 1 10–25
P2 40–50 Female 19 1 10–25
P3 30–40 Female 5 3 10–25
P4 30–40 Male 12 5 > 25
P5 50+ Male 20 1,5 10–25
P6 40–50 Female 22 10 > 10
P7 50+ Male 19 10 > 25
P8 30–40 Female 8 2 10–25
P9 30–40 Female 7 6 10–25
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contra-indications, dose reduction and switching to
drugs that are better suited based on the patient’s kidney
and liver function. The recommendation that was most
commonly mentioned was drug interactions. All physi-
cians stated that the recommendations were clinically
relevant, adequate and followed most of the time.
“Usually we say, ‘OK, good let’s do that’, and then
we change according to [the pharmacist’s]
recommendation. That is the most common, as [the
pharmacist] has such sound advice. Sometimes
there has been a discussion about a very important
drug that has been prescribed and so on, and then
we discuss whether there are other options to
consider.” (P3)
Physicians provided different reasons as to why a recom-
mendation was not followed. For example, some men-
tioned that they had already consulted another specialist,
while others said they had already thought about the sug-
gestion before the pharmacist mentioned it and had
already decided not to do anything about it. Some of the
younger physicians noted that they follow the recommen-
dations made by other specialist or a more experienced
physician rather than the one provided by the pharmacist.
Patient outcomes
All physicians perceived medication reviews performed by
a pharmacist to have a positive impact on patient out-
comes. Some mentioned that while some benefits could
be obtained while the patient is in the hospital, the impact
of medication reviews once the patient is discharged from
hospital cannot be determined. Patient outcomes attrib-
uted to the clinical pharmacy service included: reduced
risk of side-effects and interactions, and reduced length of
stay. Both physicians who have been practising medicine
for a long time and those who have been practising for a
shorter time shared this view. One physician also de-
scribed the clinical pharmacy service as an opportunity to
perform a “safety check” on the patients’ medication
treatment.
“The patient safety you can observe (…) is reduced
side-effects, reduced risk of interactions and so forth.”
“The better the medications are balanced for the
patient, the better it is. (…) I believe it is a
patient-safety issue.” (P4)
Service factors and awareness
When participants were asked what they thought the
pharmacist does on the ward, they gave different an-
swers. Some specified many different tasks while others
did not. There were differences based on the experience
and years working with the pharmacists. Many of the
older physicians were able to describe the tasks
performed by the pharmacists before the ward round.
However, most of the younger physicians described what
happens during the actual ward rounds. One of the
younger participants mentioned “I don’t really know
what she [the pharmacist] does.” (P3).
Tasks that were described included: the pharmacists
look at patients’ medical records, share drug know-
ledge, establish a protocol for each patient, suggest
things that need to be checked (e.g. laboratory values,
kidney function) and highlight problems that have been
found in a patient’s medication treatment. If all the
comments offered by the physicians are combined, this
provides a close description of what a medication
review is and what the pharmacist generally does on
the ward.
However, most physicians were unclear about the
structure of the service and how it operates. For
example, they did not know how to contact the
pharmacist, when and how often the pharmacist visits
the ward or if the pharmacist is still coming to the
ward. This was more frequent amongst physicians that
rotate between wards.
Fig. 1 Overview of the main themes that emerged from the qualitative analysis
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Suggestions to improve the service
The majority of physicians provided suggestions on how
to improve and expand the clinical pharmacy service.
These included: being able to call the pharmacist during
working hours, education about drugs and pharmaco-
logical treatments, increasing the frequency of ward
visits by the pharmacist, presentations on findings e.g.
things physicians often miss, DRPs. The majority men-
tioned that they want the service to continue, and some
physicians said that they want the service to grow and
be implemented on other wards.
“I believe that it is really good when [the pharmacist]
comes, and that [the pharmacist] is a good asset and I
hope that it will at least continue to be like this. That
[the pharmacist] will come, that [the pharmacist] will
be able to come more frequently.” (P3)
Information and cooperation were described as key
elements. As one physician explained, they “… find a
good form for it. That is, the physicians, and all staff,
need to know that we now have a pharmacist here. So
that they know it. So that I don’t start to look into things
first, and then suddenly there is another person there
who has a lot of good information. The cooperation must
be formalized so that you know that on certain days
there is this possibility, or at this time or that time.” (P6).
The clinical pharmacist
The value of the pharmacist in hospital wards
All physicians commented that it is very positive to have
a pharmacist on the ward. As described by this phys-
ician: “I believe that they [the pharmacists] have been an
asset on the ward in an area that we, and by ‘we’ I mean
physicians, often don’t have satisfactory knowledge in, i.e.
drugs, interactions and such things. So I believe that they
have contributed in a good way to the goal.” (P3).
Participants described clinical pharmacists as “helpful”
and “supportive”, an “asset” and “a resource”, but also as
“an expert that gives advice”, “a collaboration partner”,
“a colleague” and “a colleague that has a special
interest”. Some of them also mentioned that pharmacists
in general are underused in terms of the qualifications
they possess. As illustrated by this physician’s comment:
“I believe that pharmacists in general are underused in
Sweden. They study at university for ages and then sell
medications at the [community] pharmacy.” (P4).
The majority of the participants also mentioned that
they did not know how much knowledge a pharmacist
actually has until they started interacting with them. As
expected, this differed depending on the physician’s
experience with pharmacist-provided services. Before the
service was implemented in these wards the majority of
the participants considered the pharmacist’s main role is
to work in a community pharmacy. As one physician
described: “Before I have always looked upon the
pharmacist as someone working in a [community]
pharmacy.” (P3).
Most participants reported that they have interacted
with pharmacists only during ward rounds or when
community pharmacists have called them. In Sweden,
community pharmacists contact the prescribing phys-
ician if questions about the prescribed medications arise.
Some of the older physicians reported that besides the
hospital wards they have interacted with pharmacists in
drug and therapeutic committees (DTCs) or when using
the service provided by the drug information centre at
Västerbotten County Council (ELINOR). Physicians who
had interacted with pharmacists in DTCs or ELINOR
before the service was implemented in the hospital had
more understanding of what knowledge pharmacists
possess. This can be seen in the account of this
physician: “I have always had a vague idea about what a
pharmacist does, until I participated in a drug and
therapeutic committee. (…) After that I got a better
understanding of what a pharmacist does. (…) They have
much longer and more in-depth training than what I
had believed.” (P6).
The clinical pharmacist as the drug expert
Physicians often brought up drug knowledge during the
interviews, both their own knowledge and that of the
pharmacist. All the physicians described pharmacists as
“drug experts” and repeatedly mentioned the pharmacists’
pharmaceutical knowledge. In particular, drug interactions
and problems that emerge as a result of these were
mentioned by most of the participants. Some of the youn-
ger participants mentioned that they themselves lack
pharmaceutical knowledge or do not have as much know-
ledge as they would want. In contrast, older participants
described how pharmacists complemented their own
knowledge about drugs. As one physician said, “Well [the
pharmacist] has considerably deeper knowledge than I do
about specific pharmacology, so to speak. And especially
about interactions and such things that I’ve certainly read
about some time ago but have forgotten.” (P7).
Professional relationships
During the interviews the majority of physicians men-
tioned that they value the opportunity to interact with
different health care professionals as they feel that each
one can contribute with their expertise to patient care.
“Like on the rounds, that you sit down with a
physician, and a nurse, and an assistant nurse and
the pharmacist. And everyone contributes with their
expertise. The assistant nurse with nursing care and
the physician with a little medical knowledge, and the
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pharmacist who has pharmaceutical knowledge. So all
the pieces in the puzzle are there.” (P3)
“I believe it is splendid [to have different professions
present during ward rounds]. Yes, we have different
approach angles to the patients’ problems. So that
other things can crop up that you have not really
thought of.” (P7)
When talking about collaboration, some of the
physicians mentioned personal traits such as: “you
have to be humble”, “open to other individuals’
perspectives so that you can get along when you have
different opinions”, “you cannot be a dictator” and
“cannot take suggestions as criticism”. According to
these physicians, these characteristics are the basis of
good teamwork.
“You can’t take this as some sort of criticism. Instead,
this is a really good opportunity to go through the
medication lists with somebody who knows this on her
five fingers.” (P5)
Most physicians’ described that collaboration is val-
ued but at the same time they described how ultimately
they make the final decisions on how to treat patients,
or as described by this physician: “I have the final say”.
Physicians also commented on how they are used to
managing things, making evaluations, calculating risks
and determining the best way to treat patients. Most of
the physicians see the pharmacist as part of the team.
However, a couple of participants mentioned that if
continuity improved (i.e. the pharmacist was available
every day) they would be part of the team. A couple of
participants also mentioned that continuity is import-
ant “so you learn to know each other”.
Professional barriers
All of the physicians pointed out that they themselves
do not have any barriers to working with a pharma-
cist. However, there was a difference between how
younger and older physicians describe this. All but
one of the younger physicians mentioned that some
of their senior colleagues might have difficulties
working with pharmacists. One participant mentioned
that this is a new way of collaborating and “new
things are not always viewed as positive”. Another
participant reported that they have noticed tensions
between their colleagues and the pharmacists based
on comments some physicians sometimes make. Some
of the young participants also mentioned that they
have not experienced tensions but believe that they
could exist.
“Some physicians appreciate this too, and some
physicians believe that [the pharmacist] maybe is a
little too skilled as [the pharmacist] checks everything
to do with drugs and interactions and they want to
override what [the pharmacist] says sometimes.” (P1)
Older physicians however described that: “I have no
barriers”, “I don’t think that anybody has experienced
that [barriers]”, “barriers exist between all professional
roles”, “it is all about the person involved” and “it all
depends on how things are put forth”.
Some of the participants mentioned that personal
traits and the “having the right approach” are important
for pharmacists that work in hospital wards. According
to these participants pharmacists must not be too
demanding and not comment on everything they find on
a patient. One participant noted that “physicians are
people of habit”. Some physicians described how change
could be hard, especially when challenging clinical au-
tonomy. One physician reported: “They [physicians]
don’t want to be told what to do; you want to decide for
yourself and some have more difficulties taking advice
than others.” (P1).
Even though all physicians claimed not to have
barriers, some of their comments convey a somewhat
different view. One physician said: “Only physicians have
knowledge of how to treat patients”, only physicians
know “what works in real life”. Some also mentioned
that pharmacists only have “theoretical knowledge”. One
physician commented: “As a physician I have much
more, and also nurses and assistant nurses, we all have
more experience of working with a whole patient, with a
human. While I can feel that the pharmacist’s point of
departure is a little more of a theoretical one.” (P6).
Discussion
The aim of this study was to explore physicians’ percep-
tions regarding CPSs performed at hospitals operated by
Västerbotten County Council. In this study, physicians
were positive and supportive of the service and their
collaboration with the pharmacist. Pharmacists were
seen by physicians as drug experts and their recommen-
dations were perceived as clinically relevant. All
physicians wanted the service to continue and grow.
Physicians described benefits to themselves, for
example how having a pharmacist in the ward allows
them to perform other tasks, “learn” and improve their
pharmacological knowledge. Consistent with the results
of previous studies, physicians appeared to be satisfied
with the service, were able to articulate the benefits for
the patients and were likely to follow the advice
provided by the pharmacist [22–24].
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One interesting finding is that despite physicians’ posi-
tive attitude towards the service and clinical pharma-
cists, some noted they would like to perform the
medication review themselves but the lack of time
prevented them from doing it. Some also voiced strong
views about clinical autonomy, being the final decision-
maker and knowing what is best for their patients. This
is in line with previous research where the role of the
pharmacist has been described as being subordinate to
that of the physician [25]. Over the years the role of the
pharmacist has changed from traditional dispensing
roles to more patient centred services [25]. Physicians
maybe unaware of the professional skills of clinical phar-
macists. When the clinical pharmacist and the physician
start to interact and the pharmacist is able to demon-
strate his/her competence, physicians may see the poten-
tial of clinical pharmacists and their role in the health
care team. For example, a study performed by Zillich
et al., showed that trustworthiness was positively associ-
ated with physician/pharmacist collaboration, and men-
tioned that after trust is developed, physicians are more
willing to actively search for pharmacists’ advice [26].
McPherson et al. [27] noted that vocational pride, old
habits, difficulties adapting to new things and feelings of
“I know how to perform my job” and being threatened
are barriers that hinder interprofessional collaboration
(IPC). In a study about IPC between nurses, physicians’
and pharmacists, Ebert et al. [28] concluded that there is
limited understanding of other health care professionals’
roles. As described by Chisholm-Burns et al. [9], work-
ing in multiprofessional health care teams involves a
negotiated agreement between professionals who value
the contributions and expertise that various health care
professionals bring to patient care. One way to overcome
these barriers is interprofessional education (IPE). An es-
sential principle of IPE is that if students from different
health professions learn together they will be better pre-
pared for IPC via mutual understanding, communication
and trust [29, 30]. Having a common goal is another
thing that could also promote IPC.
Most physicians have little knowledge and awareness
about how the service is delivered (e.g. scheduling, fre-
quency), and saw this as an area for further improvement.
Based on consultation with the head of the ward/depart-
ment, clinical pharmacy has been tailored to each ward’s
routines and needs. For example, some wards have set
days and times while others do not. On wards that do not
have set days and times the pharmacist decides when to
attend ward rounds. Another reason for tailoring the clin-
ical pharmacy is limited resources, as there is a limited
number of clinical pharmacists employed. Awareness and
resources may be a barrier to the expansion of clinical
pharmacy services in Northern Sweden. Frequent changes
in personnel (ward turnover and new physicians) can also
create difficulties in terms of continuity, awareness and
building interprofessional relationships [22]. It is interest-
ing to note that the suggestions to improve the service
provided by physicians (i.e. being able to call the pharma-
cist, presentation of statistics) are services that are
currently being provided, highlighting once more the
importance of increasing awareness.
Implications for practice
To date, few wards operated by Västerbotten County
Council have implemented CPSs. However, since this
study was completed the service has been implemented in
more wards and hospitals in the region. Still, the situation
in Northern Sweden is similar to other countries [31, 32],
not only in Europe but also elsewhere [33–35]. Physicians
in this study described pharmacists as drug experts with
pharmaceutical knowledge. Against this background, in-
cluding clinical pharmacists in the health care team might
optimize drug therapy and ensure patient safety, which
could reduce DRPs and health care costs [15].
Physicians’ attitudes toward CPSs and collaborating
with clinical pharmacists may facilitate or hinder the im-
plementation and expansion of the services and the role
of clinical pharmacist on hospital wards. For CPSs to be
successfully implemented, to be sustainable and to grow,
the roles, abilities and responsibilities of the clinical
pharmacist need to be clearly described and there need
to be opportunities to support collaborative relationships
not only with physicians but with other health care
practitioners. It is also important that decision-makers
support the implementation of CPSs.
Strengths and limitations
The results of this study need to be considered in the light
of the limitations of the research. All of the interviewed
physicians were positive and had similar views. Perhaps
those who chose to participate were more likely to have
positive views compared to those who decided not to par-
ticipate. Furthermore, interviews were conducted by a
Master’s in Pharmacy student and hence participants may
have provided overall positive views. Participants might
have felt uncomfortable expressing views that could be
perceived as something negative about pharmacists. How-
ever, participants spoke freely during the interviews and
the researcher perceived no implications of participants
feeling uncomfortable. Also, the coders were all pharma-
cists, which might have contributed to a more positive in-
terpretation of the results.
Interviews were conducted in Swedish and then
reported in English. Considering that the purpose of the
study was to convey views expressed by the participants,
this could be difficult when quotes that are supposed to
support the findings have to be translated as it is easy for
their meaning to be “lost in translation” [36]. However, as
Vinterflod et al. BMC Health Services Research  (2018) 18:35 Page 7 of 9
previously mentioned, quotes were also back translated
into Swedish. Culture and the way opinions are described
may also have played a role. “Lagom” is a Swedish word
meaning “just the right amount”. This is particularly
reflected in the participants’ responses (not too negative,
not too positive, just the right amount).
Even though the number of interviews conducted in
this study was small, data saturation was reached. It is
also important to highlight that the sample size also
reflects the restraints of the small size of the current
service. Currently, the service is only provided in some
wards on certain days and by two clinical pharmacists.
The number of physicians that have contact with phar-
macists more than occasionally is limited. As described
by Fusch and Ness [19] data saturation is not about the
numbers but about the depth of the data. A small
sample size may be more useful in examining a situ-
ation, while a large sample would be inconsequential.
To date, most studies have focused on measuring
health care providers’ satisfaction with CPSs via surveys
[23, 33–35]. To our knowledge this is one of the few
interview studies in this area conducted in Sweden.
Conclusion
This study provides an in-depth exploration of physicians’
views and experiences of the service, provides insight into
how physicians perceive the service and the pharmacists’
role and what they perceive to be the impact on patient
outcomes. Since CPSs might be of special importance in
Northern Sweden, the findings that all physicians were
positive regarding CPSs and were satisfied with the collab-
oration with the clinical pharmacists, are important to put
forward in order to further implement and expand CPSs.
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